Insulet (PODD) Announces Proposed $450M Financing Transactions
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Insulet Announces Proposed Financing Transactions
March 18, 2025 7:35 AM EDTACTON, Mass.--(BUSINESS WIRE)-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its intention to offer, subject to market and other conditions, $450 million aggregate principal amount of senior unsecured notes due 2033 (the Notes) in a private placement.
The Company intends to use the net proceeds from the Notes offering, together with cash on hand and potentially cash from partially terminating the Companys existing capped call transactions relating to the Companys existing 0.375% Convertible Senior Notes due 2026 (the Convertible... More
